Three-year follow-up study of allergy in workers in a mushroom factory  by TANAKA, H et al.
Vol.95 (2001) 943^948Three-year follow-up study of allergy inworkers
in a mushroom factory
H.TANAKA*,T. SAIKAI*,H. SUGAWARAw, K.TSUNEMATSUw, I.TAKEYAw,H.KOBA*,
A.MATSUURAz, K. IMAI} AND S. ABE*
*Third and }First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo,
wTomakomai Prefecture Hospital,Tomakomai and zSecond Department of Pathology, Fujita Health University School
of Medicine,Toyoake, Japan
Abstract Exposure to mushroom sporesmay causemany respiratory allergic diseases, however, there has been no
serial study in amushroom factory to address this problem.The aim of this study was to investigate the serial changes in
respiratory allergy and the incidence of hypersensitivity pneumonitis (HP) in mushroomworkers. A 3-year follow-up
study, beginning in June1996, was conducted in a newly operatingmushroom factory inwhich one kind of mushroom is
produced: Hypsizigus marmoreus (Bunashimeji). Allergic symptoms, chest roentgenogram, serum precipitins to the
spores and soluble adhesionmolecules in sera were evaluated once a year in 60 workers and 20 controls.Three out of
the 60 subjectswere diagnosed as having HPcaused by inhalation of themushroom spore and they were therefore ex-
cluded fromthis study, and the 57 non-HP subjects were evaluated. In this study 24 workers quit because of intolerable
cough, runnynose,wheezing, sputum, feverelevationand/or shortnessof breathattheirplaceofwork.Duringeachyear
ofthis studyasmanyas 70^80% ofemployees su¡ered someofthe above symptoms, coughbeing themostfrequent, and
positive rate of serum precipitins to the spore revealed 30% in 1996, 93% in 1997 and 94% in 1998. From the June 1996
examination until the following May, serum soluble intercellular adhesion molecule-1 levels of the 15 workers who quit
during that period were signi¢cantly higher than those in the 42 workers still employed in 1997 (Po0?05).Workers in
Bunashimejimushroom factoriesmight be at critical riskof developing respiratory allergy.In our 3-year study, over 90%
workers were sensitized to the spore,40% quit because of the symptoms and 5% developed HP. It was suggested that
workers should be counselled about the risk of mushroom allergy and precautionary measures should be taken to
prevent its occurrence.r2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1187, available online at http://www.idealibrary.comon
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Mushroom spores can cause respiratory allergic dis-
eases such as asthma and hypersensitivity pneumonitis
(HP), and these disorders have been increasing in recent
years (1^7). Hypsizigusmarmoreus, called ‘Bunashimeji’ in
Japanese, is one of the common edible mushrooms. As
cultivation takes place indoors, when they are fully
grown, the cultivating, harvesting and packing rooms
are ¢lled with the mushroom spores, because Bunashi-
meji is ‘open’ very early and releasing spores well before
harvest. The size of the Bunashimeji spores is 4^6mmReceived15 September 2000, accepted in revised form15 June 2001and
published online 24 October 2001.
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reported two cases with HP caused by the spore (8).
Only one cross-sectional survey of mushroom workers
has been published (9), and it stated that all mushroom
farm workers should be counselled about the risk of
developing HP and advised on the symptoms and warn-
ing signs of HP. However, there has been no follow-up
study of the health problems of workers in this industry.
Intercellular adhesionmolecule-1 (ICAM-1) and vascu-
lar cell adhesion molecule 1 (VCAM-1) are members of
the immunoglobulin supergene family, and the principal
ligands for leukocyte functional antigen-1 and vascular
leukocyte antigen-4 (VLA-4), respectively. The soluble
forms of these adhesion molecules might be useful
markers formonitoring the activity of in£ammatory and
immune diseases (10^12).
To investigate the serial changes in respiratory allergy
and the incidence of HP in mushroomworkers, we con-
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producing Bunashimeji.We also measured serum preci-
pitins to the mushroom and serum soluble forms of
adhesionmolecules as evidence to support the existence
ofmushroom allergy.
MATERIALSANDMETHODS
Study population
This factory, which produces only the Bunashimeji
mushroom, had a total of 72 employees in June 1996;
two were o⁄ce workers, and the other 70 people were
working in cultivation, harvesting and packing of the
mushrooms. All their jobs involved rotating freely
between the cultivation room, the harvesting and
packing area, and the maintenance place every day.This
factory produced mushrooms 6 days a week in all
seasons. Out of the 70 workers exposed to mushroom
spores, 60, aged between 34^66 years (4976 years), all
of whomwerewomen,were chosen toparticipate in this
study after giving informed consent. A research ethics
committee inTomakomai Prefecture Hospital approved
this study.Out of the 60 workers, 45 were non-smokers
and 15 were current or former smokers. As a control
group,we chose 20 age-and sex-matchedcontrolwomen
(4877 years) who had just began working at a new,
neighbouring, mushroom factory, but had never been
engaged in cultivating Bunashimeji prior to that. These
20 subjects had been housewives or o⁄ce workers
before this employment, and no subjects with allergic
symptomswere included.
Study design
The follow-up investigations were performed in June
1996, June 1997 and June 1998.We assessed the subjects
for six allergic symptoms by means of a questionnaire,
chest roentgenogram, serum precipitin antibodies to
the Bunashimeji’s spores and serum sICAM-1. The
self-administered questionnaire asked whether cough,
sputum, wheezing, shortness of breath, fever or
runny nose appeared after work in this mushroom
factory. Chest ¢lms were interpreted by two thoracic
radiologists.
Serum sVCAM-1 levels and the atopic status of the
workers were evaluated only in the 1996 examination.
Subjects were de¢ned as non-atopic when they had no
positive antigen speci¢c serum IgE, and de¢ned as atopic
when they had at least one or more positive antigens
to 12 common antigens tested by a commercial kit
(CAP Phadiatop FEIA, Pharmacia and Upjohn, Uppsala,
Sweden). In the 60 workers, 20 were atopic and the
remaining 40 were non-atopic.Mushroomexposure
Measurement of airborne spore for determination of
b-D-glucan level was made by drawing air through a
110-mm diameter glass ¢ber of 0?6mm porosity
(GB-100R, Toyo Roshi, Tokyo, Japan) at a £ow rate of
500 lminÿ1 for 30min using a high volume air sampler.
The air inlet of the sampler was attached at the subject’s
nose level. The ¢lters were shaken for 10 min in 10 ml
distilled water. Twenty-¢ve microlitres of the extract
and 100ml glucan speci¢c lysate (Fungitic G test;
Seikagaku Kogyo, Japan) were added. The plate was
incubated in a spectrometer, and the kinetics of the
ensuing color reaction was read photometrically.
Sampling consisting three measurements involved three
¢lters in the cultivating room, three in the harvesting
and packing area, and three in the o⁄ce room. The
limitation of detection was 20pgmlÿ1 for b-D-glucan.
The mean concentrations of airborne b-D-glucan were
1?0ngmÿ3 in the cultivating room, 3?0ngmÿ3 in the
harvesting and packing area and 0?3ngmÿ3 in the o⁄ce
room.
Mushroomspore antigens preparation
The spores of Bunashimeji were collected from the
mushroom in a sterilized method at this farm, and
cultured in Sabouraud’s glucose broth. The cultured
spores and their proteins were extracted with 50%
ammonium sulfate. The sample was centrifuged at
3000 rpm for15min and the pellet was dialysedwith dis-
tilledwater.
Serumprecipitins to Bunashimeji
The double di¡usion test for precipitating antibodies
for HM was performed according to the method of
Ouchterlony (13). Fifty microlitres of antigen and/or
serumwere added to opposite well of 1% agarose plates
and monitored for 72h at room temperature. The fol-
lowing antigens: Micropolyspora faeni, Thermoactinomyces
vulgaris (prepared in our laboratory) and Aspergillus fumi-
gatus (Hollister-Stier, Spokane, Washington, U.S.A.)
were also tested in the samemanner.
Measurement of serumsICAM-1and
sVCAM-1levels
Double-determinant immunoassay (DDIA) using the
FAST system (Becton Dickinson, Mountain View, CA,
U.S.A.) was employed in order to measure the levels of
sICAM-1 in serum. This DDIA for measurement of
sICAM-1 has previously been described (14). Two
monoclonal antibodies (CL207 and HA58) that
recognize di¡erent epitopes of ICAM-1were used in the
DDIA. Brie£y, the beads attached to the lip of a 96-well
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then non-speci¢c binding was blocked with PBS
(pH=7?4) containing 3% bovine serum albumin at 371C
for 2h. Aliquots of serum samples diluted 1: 200 in PBS
were then incubated with the bed for 2h. After being
washed with PBS containing 0?05% Tween 20, the beads
were incubated with biotinylated HA58 for 2h.
Avidin-conjugated peroxidase (Vector, Burlingame, CA,
U.S.A.) was diluted 1:1000 in 0.05M PBS with 0.5M NaCl
pH 8.0, and incubatedwith thebeds for1h.The degree of
substrate reactionwas determinedwith OPD at 495nm
in a Micro-ELISA Auto Reader MR 580 (Dynatech,
Cambridge, MA, U.S.A.). Results were expressed as
ngmlÿ1 calculated from the titration curve of the
ICAM-1 antigen. Serum levels of sVCAM-1 were
measured using a commercial ELISA kit (Human
VCAM-1 ELISA kit, R&D Systems, MA, U.S.A.). ELISA
was performed according to the manufacturers’
instructions.Results were expressed in terms of ngmlÿ1
calculated from the titration curve of VCAM-1.
Diagnosis of HP by Bunashimeji spores
HP was diagnosed by the following criteria: (1) episodes
of cough, dyspnoea and fever occurring somehours after
work; (2) auscultatory evidence of crepitations; (3)
di¡use reticulonodular opacities on chest radiograph or
computer tomography; (4) pulmonary function test
revealing a reduction in vital capacity, carbon monoxide
di¡using capacity, and arterial PaO2; (5) presence of
serum precipitins to Bunashimeji and no precipitins to
the antigens of Micropolyspora faeni and Thermoactino-
myces vulgaris; (6) positive result for in vitro blastogenesis
of bronchoalveolar lavage £uid (BALF) lymphocytes to
the mushroom antigens; (7) an increased number of
T-lymphocyte in BALF; (8) the presence on a transbron-
chial biopsy of bronchiolitis and interstitial pnuemonitis,
frequently with granuloma formation; (9) resolution of
the episodic respiratory symptoms after cessation of
exposure the spore of Bunashimeji.
Statistical analysis
Data on serum soluble adhesionmolecules arepresented
as mean7SD. The chi-square test was used to test the
comparison of the positive rates of the precipitins
between the workers and controls. Comparisons of
serum sICAM-1 and sVACM-1 levels in 1996 among the
three groups shown in Fig.1 and serial changes in serum
sICAM-1 levels revealed in Table 1 were assessed by
analysis of variance (ANOVA) and Sche¡e’s test. Serum
adhesion molecules in the workers and quitters were
compared with the Mann^Whitney U-test. Statistical
signi¢cancewas assumed for P-values lower than 0?05.RESULTS
During this study three of the 60 subjects were
diagnosed with HP induced by the spore of Bunashimeji,
and two of these cases had already been documented
(8). In this survey, abnormal shadow could be detected
on chestroentgenogram in only these threeHPpatients.
Consequently, these three patients were excluded
from the evaluation and the 57 mushroom workers
withoutHPwere assessed.None of the control subjects
had the symptoms at the work place or serum
precipitins to the Bunashimejimushroom. Serial changes
in the number of symptomatic workers, the frequency of
each symptom, serum sICAM-1 levels, and positive rate
of serumprecipitins are shown inTable1.Fifteenworkers
quit from this factoryduring1year from June1996 toMay
1997 and ninemore subjects during the following year. A
total of 24 employees (40% of the original 60 subjects)
stopped working because they could no longer tolerate
the symptoms during this study.The incidence of allergic
symptoms at the workplace was 80% of the subjects in
1996, 76% of those still employed in 1997 and 73% in
1998.Thirty per cent of the workers were sensitized to
themushroom spore in the1996 examination, and in1997
and 1998 this ¢gure had become 93% and 94%
respectively of theworkers still in employment.No pre-
cipitins in sera to the antigens of Micropolyspora faeni,
Thermoactinomyces vulgaris or Aspergillus fumigatus were
found. Serial changes in serum sICAM-1 levels were not
signi¢cantly di¡erent among the three measurements
(Table1).
The serum sVCAM-1 levels of 17 workers who
precipitin positive were signi¢cantly higher than those
of both 40 negative subjects and controls
(534774ngmlÿ1 vs. 465794 and 463768; P=0?033,
P=0?013, respectively) (Fig. 1). The levels of sICAM-1 in
precipitin positive subjectswere signi¢cantly higher than
those of controls (149750ngmlÿ1 vs. 116727; P=0?012)
(Fig.1).Thepositive rate of precipitins to the Bunashimeji
spore in 1996 in smokers was higher than that in
non-smokers, but not signi¢cantly (36% vs.16%,NS).
Serum sICAM-1 levels of the 15 quitters, but not
sVCAM-1 levels, were higher than those of the other 42
subjects (156713ngmlÿ1 vs. 13076, P=0?044) (Fig. 2).
No signi¢cant di¡erences were observed in serum
sICAM-1or sVCAM-1 levels between13 smokers and 44
non-smokers, or between 19 atopic workers and 38
non-atopic subjects.
DISCUSSION
Mushrooms are usually cultivated indoors in Japan and
workers are exposed to a high concentration of spores
such as Lentinus edodes (Shiitake) or Pholiota nameko
(Nameko). Our results revealed that in the ¢rst year
80% of the workers noticed symptoms associated with
TABLE 1. Serial changes in symptoms, serum soluble ICAM-1levels andprecipitin antibodies in 57 mushroomworkers hyper-
sensitivitypneumonitis
June1996 June1997 June1998
Workers still employed (n) 57 42 33
Quitters (n) ^ 15 24
Symptomsinworkers still employed 46 (80%) 32 (76%) 24 (73%)
Cough 42 29 20
Sputum 10 7 6
Wheezing 12 8 6
Fever 9 6 4
Shortness of breath 9 6 5
Runnynose 23 15 10
Serum sICAM-1(mean7SD) 142747 ngmlÿ1 122732 ngmlÿ1 109732 ngmlÿ1
Positive serumprecipitins 17 (30%) 39 (93%) 31 (94%)
FIG. 1. Comparisons of serum sVCAM-1 (left) and sICAM-1
(right) levels in June1996 examination among three groups using
the ANOVA; controls, workerswith negative serumprecipitins
tothemushroom, andworkerswithpositiveprecipitins.Boxplot
represent the median and 25th^75th percentiles; error bars
span10th^90th percentiles.
FIG. 2. Comparisons of serum sVCAM-1 (left) and sICAM-1
(right) values in the1996 examination betweenworkers still em-
ployed in1997 and quitters after the1996 examination.Box plot
represent the median and 25th^75th percentiles; error bars
span10th^90th percentiles.
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the 60workers quitbecause their respiratory symptoms
became intolerable. These results suggested that this
mushroom factory is a signi¢cant risk factor for allergic
diseases.Moreover, serumprecipitins to the Bunashimeji
mushroom were positive in 30% of the subjects in
the ¢rst year, but in the second year this ¢gure was,
surprisingly, as high as 93%. A cross-sectional health
study of mushroom farm workers in Florida (9), where
Agaricus bisporuswas the prevalent spore, demonstrated
that only 15 out of 227 workers (7?5%) had positive
serum precipitating antibody to Agaricus bisporus.
Another study of several ‘Shiitake’ mushroom farms in
Japan revealed that three out of 37 workers (8?1%) had
positive precipitins to the antigens of ‘Shiitake’ (2). Incontrast however, antibodies were found not only in
almost all a¡ected persons but also in 50% of asympto-
matic persons who worked with the mushroom (15). In
one study, in which subjects had not engaged in
mushroom production, serum precipitating antibodies
provided a useful marker of exposure to mushroom
spores, but were not speci¢c to an allergic respiratory
disease or their predictors (16,17). In our study, no
workers had previously engaged in mushroom produc-
tion, therefore the high incidence of symptoms and high
positive precipitin rate might have been due to the
inhalation of a high concentration of the spore. These
results suggested that contemporary mushroom
factories are of signi¢cant risk for sensitization to
mushroom antigens. Moreover, all mushroom antigens
can cause respiratory allergic diseases.
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actions of all the Gell and Coombs types I^IV (18), but
the overall prevalence and incidence of mushroom
allergic diseases remains unknown. The complaints of
common mushroom workers include the following
symptoms: dyspnoea, fever, chill, coughing, malaise,
chest pain and headache, appearing 5^10h after antigen
provocation (19). Our results revealed that 80% of 57
workers had one or more of these symptoms, whereas
in the Floridamushroomreport only 21% of 259workers
had them (9). In our study, the symptoms most
frequently reported were cough (60^73%), followed by
runny nose (30^40%), wheezing (18^24%) and in the
Florida study cough was 17%, fatigue 16% and myalgia
15%.The di¡erence in the prevalencemay have been due
to the subject selection procedures. We selected a
subgroup thatmight havebeen inhaling a high concentra-
tion of mushroom spores, but this was not the case in
the Florida study. Recent studies have indicated that
occupational anaphylactic reaction, asthma and extrinsic
allergic alveolitis by the inhalation of mushroom spores
were frequent among atopic asthmatics (20,21). How-
ever there were no such trends in the present study.
Two of the threeHPpatientswerenon-atopic, and there
were no signi¢cant di¡erences in circulating levels of sI-
CAM-1 or sVCAM-1 between atopic and non-atopic
subjects.
The serum sICAM-1 concentrations of quitters were
higher than those of workers still employed in the
factory and the levels in precipitin positiveworkers were
higher than those in controls. These results supported
the fact that allergic reactions existed in mushroom
workers. Serial changes in the incidence of allergic
symptoms and serum sICAM-1levels inworkerswithout
HP had a tendency to decrease. This might have
been caused by exclusion of the quitters, who had
high levels of sICAM-1, meaning that the relative
increase in the health of these mushroom workers
was in fact a statistical illusion. On the other hand,
circulating sVCAM-1 levels were signi¢cantly higher
in precipitin positive workers in this study. VCAM-1 is
enhanced by Th2 cytokines like IL-4 and IL-13 (22,23).
IL-4 is also capable of up-regulating theVLA-4-VCAM-1
pathway, which may play a part in both eosinophil and
T-cell migration (24). Nakajima et al. (25) reported
that the expression of VCAM-1 was induced for the
¢rst time on the endothelium after inhaled antigen
challenge in sensitized mouse; however ICAM-1 had
already been expressed to some extent before the
challenge. One possible explanation for the elevation
of sVCAM-1, but not of sICAM-1 in precipitin
positive workers could be that VCAM-1 expression
might be enhanced for the ¢rst time by the spore-in-
duced Th2-cytokine immunoreaction, which would up-
regulate antibody production including precipitins to
Bunashimeji.The level of airborne spore for determination of
b-D-glucan was about 10 times higher in the harvesting
and packing area as compared with that in the o⁄ce
room. However, workers in this study may have been
exposed to a similar level of mushroom spores because
all their jobs involved rotating freely between the
cultivation room and the harvesting and packing
area every day. After this survey, the employees
were required to wear protective masks (8), and a part
of the harvesting and packing process became
automated.
In conclusion, three subjects developed HP by
inhalation of the mushroom spore in this 3-year follow-
up study. About 70^80% of the workers had allergic
symptoms, 93% of the employees were sensitized to the
sporewithin 2 years and 40%of the originalworkers quit
because of the symptoms. These clinical ¢ndings were
supportedby the elevation of soluble adhesionmolecules
in sera. Contemporary mushroom factories are places
where there is substantial risk of the occurrence of
occupational allergic diseases.
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